These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 36303103)

  • 21. Management of submacular hemorrhage with intravitreal versus subretinal injection of recombinant tissue plasminogen activator.
    Hillenkamp J; Surguch V; Framme C; Gabel VP; Sachs HG
    Graefes Arch Clin Exp Ophthalmol; 2010 Jan; 248(1):5-11. PubMed ID: 19669780
    [TBL] [Abstract][Full Text] [Related]  

  • 22. STEP-WISE APPROACH TO THE MANAGEMENT OF SUBMACULAR HEMORRHAGE USING PNEUMATIC DISPLACEMENT AND VITRECTOMY: The Manchester Protocol.
    Chew GWM; Ivanova T; Patton N; Dhawahir-Scala F; Jasani KM; Turner G; Charles S; Jalil A
    Retina; 2022 Jan; 42(1):11-18. PubMed ID: 34469407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of submacular hemorrhage with tissue plasminogen activator and pneumatic displacement in age-related macular degeneration.
    Sniatecki JJ; Ho-Yen G; Clarke B; Barbara R; Lash S; Papathomas T; Antonakis S; Gupta B
    Eur J Ophthalmol; 2021 Mar; 31(2):643-648. PubMed ID: 31813290
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcomes of vitrectomy combined with subretinal tissue plasminogen activator injection for submacular hemorrhage associated with polypoidal choroidal vasculopathy.
    Kimura S; Morizane Y; Hosokawa MM; Shiode Y; Doi S; Hosogi M; Fujiwara A; Okanouchi T; Inoue Y; Shiraga F
    Jpn J Ophthalmol; 2019 Sep; 63(5):382-388. PubMed ID: 31243593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant tissue plasminogen activator, vitrectomy, and gas for recent submacular hemorrhage displacement due to retinal macroaneurysm.
    van Zeeburg EJ; Cereda MG; van Meurs JC
    Graefes Arch Clin Exp Ophthalmol; 2013 Mar; 251(3):733-40. PubMed ID: 22865261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TISSUE PLASMINOGEN ACTIVATOR FOR SUBFOVEAL HEMORRHAGE DUE TO AGE-RELATED MACULAR DEGENERATION: Comparison of 3 Treatment Modalities.
    Fassbender JM; Sherman MP; Barr CC; Schaal S
    Retina; 2016 Oct; 36(10):1860-5. PubMed ID: 26945238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subretinal Injection of Recombinant Tissue Plasminogen Activator and Gas Tamponade to Displace Acute Submacular Haemorrhages Secondary to Age-Related Macular Degeneration.
    Iannetta D; De Maria M; Bolletta E; Mastrofilippo V; Moramarco A; Fontana L
    Clin Ophthalmol; 2021; 15():3649-3659. PubMed ID: 34483653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sequential tissue plasminogen activator, pneumatic displacement, and anti-VEGF treatment for submacular hemorrhage.
    Bardak H; Bardak Y; Erçalık Y; Erdem B; Arslan G; Timlioglu S
    Eur J Ophthalmol; 2018 May; 28(3):306-310. PubMed ID: 29148027
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Submacular hemorrhage in polypoidal choroidal vasculopathy treated by vitrectomy and subretinal tissue plasminogen activator.
    Kimura S; Morizane Y; Hosokawa M; Shiode Y; Kawata T; Doi S; Matoba R; Hosogi M; Fujiwara A; Inoue Y; Shiraga F
    Am J Ophthalmol; 2015 Apr; 159(4):683-9. PubMed ID: 25555798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Timing of Large Submacular Hemorrhage Secondary to Age-Related Macular Degeneration Relative to Anti-VEGF Therapy.
    Matsunaga DR; Su D; Sioufi K; Obeid A; Wibbelsman T; Ho AC; Regillo CD
    Ophthalmol Retina; 2021 Apr; 5(4):342-347. PubMed ID: 32763426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intravitreal Recombinant Tissue Plasminogen Activator and Sulphur Hexafluoride Gas for Submacular Haemorrhage Displacement in Age-Related Macular Degeneration: Looking behind the Blood.
    Maggio E; Peroglio Deiro A; Mete M; Sartore M; Polito A; Prigione G; Guerriero M; Pertile G
    Ophthalmologica; 2020; 243(3):224-235. PubMed ID: 31905361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. VITRECTOMY WITH SUBRETINAL INJECTION OF RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR FOR SUBMACULAR HEMORRHAGE WITH OR WITHOUT VITREOUS HEMORRHAGE.
    Shi T; Wen J; Xia H; Chen H
    Retina; 2024 Jul; 44(7):1188-1195. PubMed ID: 38452260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subretinal injection of recombinant tissue plasminogen activator for submacular hemorrhage associated with ruptured retinal arterial macroaneurysm.
    Inoue M; Shiraga F; Shirakata Y; Morizane Y; Kimura S; Hirakata A
    Graefes Arch Clin Exp Ophthalmol; 2015 Oct; 253(10):1663-9. PubMed ID: 25418034
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PREDICTORS OF 3-MONTH AND 1-YEAR VISUAL OUTCOMES AFTER VITRECTOMY WITH SUBRETINAL TISSUE PLASMINOGEN ACTIVATOR INJECTION FOR SUBMACULAR HEMORRHAGE.
    Miki M; Miyata M; Ooto S; Tamura H; Ueda-Arakawa N; Muraoka Y; Miyake M; Hata M; Takahashi A; Kido A; Kogo T; Uji A; Tsujikawa A
    Retina; 2023 Nov; 43(11):1971-1979. PubMed ID: 37490778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. VITRECTOMY WITH SUBRETINAL TISSUE PLASMINOGEN ACTIVATOR AND GAS TAMPONADE FOR SUBFOVEAL HEMORRHAGE: Prognostic Factors and Clinical Outcomes.
    Plemel DJA; Lapere SRJ; Rudnisky CJ; Tennant MTS
    Retina; 2019 Jan; 39(1):172-179. PubMed ID: 29135798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined treatment of submacular hemorrhage with low-dose subretinal recombinant tissue plasminogen activator and intravitreal conbercept.
    Ma Y; Rao S; Tan Y; Du H; Sun X
    BMC Ophthalmol; 2024 Sep; 24(1):395. PubMed ID: 39237907
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pars plana vitrectomy, subretinal injection of tissue plasminogen activator, and fluid-gas exchange for displacement of thick submacular hemorrhage in age-related macular degeneration.
    Haupert CL; McCuen BW; Jaffe GJ; Steuer ER; Cox TA; Toth CA; Fekrat S; Postel EA
    Am J Ophthalmol; 2001 Feb; 131(2):208-15. PubMed ID: 11228297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Visual Recovery and Prognosis in the Treatment of Submacular Hemorrhage due to Polypoidal Choroidal Vasculopathy and Retinal Arterial Macroaneurysm: A Retrospective Study.
    Wu J; Yan T; Zhang R; Feng C; Xu C; Xu T; Li Y; Wang S; He J
    Int J Clin Pract; 2023; 2023():3880297. PubMed ID: 37342617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Subretinal coapplication of recombinant tissue plasminogen activator and bevacizumab for neovascular age-related macular degeneration with submacular haemorrhage.
    Treumer F; Klatt C; Roider J; Hillenkamp J
    Br J Ophthalmol; 2010 Jan; 94(1):48-53. PubMed ID: 19946027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of submacular hematoma by vitrectomy, subretinal injection of rtPA and gaseous tamponade: A single-center retrospective observational study].
    Berthon C; Rousseau E; Chiambaretta F
    J Fr Ophtalmol; 2020 May; 43(5):417-426. PubMed ID: 32192752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.